Jin10 Data reported on August 21 that Menco Pharmaceutical announced that shareholders JSR Limited and Best Idea International Limited plan to participate in the pre-IPO shareholder Inquiry transfer, intending to transfer a total of 22,946,200 shares, accounting for 3.50% of Menco Pharmaceutical's total share capital. This transfer is a private transfer, with the transferee being institutional investors with corresponding pricing capabilities and risk tolerance. The lower limit of the transfer price shall not be less than 70% of the average trading price of the stocks in the 20 trading days prior to the date of sending the subscription invitation (i.e., August 21, 2025, inclusive).
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
MediTech Pharma: Shareholder plans to transfer 3.5% of shares
Jin10 Data reported on August 21 that Menco Pharmaceutical announced that shareholders JSR Limited and Best Idea International Limited plan to participate in the pre-IPO shareholder Inquiry transfer, intending to transfer a total of 22,946,200 shares, accounting for 3.50% of Menco Pharmaceutical's total share capital. This transfer is a private transfer, with the transferee being institutional investors with corresponding pricing capabilities and risk tolerance. The lower limit of the transfer price shall not be less than 70% of the average trading price of the stocks in the 20 trading days prior to the date of sending the subscription invitation (i.e., August 21, 2025, inclusive).